Prostatakarzinom: Neues aus der Forschung der Nuklearmedizin

Leitender Oberarzt Dr. med. Reinhard Thamm des Universitätklinikums Ulm, stellt die Poster "Detection rate, pattern, and inter-observer variability of 68-Ga-PSMA-PET/CT in post-prostatectomy patients with PSA progression up to 0.5 ng/ml" und "Changes of radiotherapeutic treatment concept based on 68‐Gallium‐PSMA‐PET/CT (“PET/CT”) in PSA‐recurrences up to 0.5 ng/ml" vor.

Nuklearmedizin: Neues zum Prostatakarzinom

Leitender Oberarzt Dr. med. Reinhard Thamm des Universitätklinikums Ulm, stellt die Poster "Detection rate, pattern, and inter-observer variability of 68-Ga-PSMA-PET/CT in post-prostatectomy patients with PSA progression up to 0.5 ng/ml" und "Changes of radiotherapeutic treatment concept based on 68‐Gallium‐PSMA‐PET/CT (“PET/CT”) in PSA‐recurrences up to 0.5 ng/ml" vor.